IGC Pharma Adds Visionary Investigators Network as Clinical Site to Phase 2 CALMA Trial
Comments Off on IGC Pharma Adds Visionary Investigators Network as Clinical Site to Phase 2 CALMA Trial
February 23, 2026
WHY IT MATTERS: If you or a loved one is living with Alzheimer's-related agitation, the expansion of this clinical trial means more opportunities to access investigational cannabinoid therapy and brings us closer to having FDA-reviewed evidence for…
Endocannabinoid System in Older Adults: 7 Essential Insights
Comments Off on Endocannabinoid System in Older Adults: 7 Essential Insights
January 20, 2026
ECS and aging
Cannabis Use in Older Adults Is Rising—Now What?
Older adults are turning to cannabis in record numbers—but you wouldn’t know it from most medical offices. This isn’t a rebellion—it’s a quiet referendum on how we handle chronic illness, aging, and autonomy. The question isn’t whether it’s happening—the…